Nu Skin Enterprises NUS shares are trading sharply lower after the company reported worse-than-expected preliminary second-quarter EPS and sales results. The company also cut its sales guidance below analyst estimates.
On Tuesday afternoon, Nu Skin cut it preliminary 2019 sales guidance from $2.76 billion-$2.81 billion to $2.48 billion-$2.52 billion versus a $2.77 billion estimate.
On Wednesday morning, DA Davidson downgraded Nu Skin Enterprises from Buy to Neutral and lowered the price target from $88 to $38.
Nu Skin Enterprises traded down 19.69% at $36.55 per share in the pre-market session. The stock has a 52-week high of $88.68 and a 52-week low of $43.57.
Related Links:
Jefferies Offers 4 Reasons To Like Nu Skin Enterprises
Nu Skin Spikes to High of $53.29 on Najarian/CNBC Mention of Earlier Call Activity
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
